Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Initiates Coverage On Rapid Micro Biosystems with Outperform Rating

Cowen & Co. analyst Max Masucci initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with a Outperform rating.
byBenzinga Newsdesk
August 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Max Masucci initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with a Outperform rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Beam Therapeutics Expects Cash, Cash Equivalents, And Marketable Securities Of $1.1B Will Enable The Company To Fund Its Anticipated Operating Expenses And Capital Expenditure Requirements At Least Into 2025

By Benzinga Newsdesk
Today, 11:19 AM
This expectation includes funding directed toward reaching each of the key milestones for BEAM-101, BEAM-201, BEAM-301 and BEAM-302 described above, as well as continued investments in platform advancements and

BEAM